About Biopol Chemicals Ltd
Biopol Chemicals is engaged in the business of manufacturing and distribution of specialty chemicals under the categories of silicones, emulsifiers, biochemicals and polyelectrolytes. Our product portfolio consists of 66 products which comprises of 40 silicone-based products, 5 emulsifier-based products,
Founded
2023
CEO
Santanu Sarkar
Employees
21
HQ
Parganas (North), India
Finished Products
1Textile Chemical
₹41.56Cr2Industrial Chemical
₹5.12Cr3Personal & Home Care
₹1.50Cr4Consultancy Services
₹0.81Cr5Agriculture
₹0.13CrRaw Materials
1Purchases of Stock in Trade
₹27.33Cr2Cost of Material Consumed
₹15.86CrAbout Biopol Chemicals Ltd
Biopol Chemicals is engaged in the business of manufacturing and distribution of specialty chemicals under the categories of silicones, emulsifiers, biochemicals and polyelectrolytes. Our product portfolio consists of 66 products which comprises of 40 silicone-based products, 5 emulsifier-based products,
Founded:2023
CEO:Santanu Sarkar
Employees:21
HQ:Parganas (North), India
Finished Products
1Textile Chemical
₹41.56Cr2Industrial Chemical
₹5.12Cr3Personal & Home Care
₹1.50Cr4Consultancy Services
₹0.81Cr5Agriculture
₹0.13CrRaw Materials
1Purchases of Stock in Trade
₹27.33Cr2Cost of Material Consumed
₹15.86CrPrice Performance & Market EventsPrice Performance
Loading chart data…
Key Metrics
Trading & valuation snapshot
52W High
₹134
52W Low
₹42
Volume57.60K
Avg VolumeN/A
BetaN/A
Dividend Yield0.00%
Key Financial Ratios
Profitability, leverage & efficiency at a glance
P/E Ratio
N/A
Valuation
P/B Ratio
0.90x
Valuation
EPS
₹0.00
Valuation
Dividend Yield
0.00%
Valuation
ROE
17.98%
Profitability
ROCE
23.26%
Profitability
Revenue by Segment
Contribution & growth by business line
Trading and manufacturing of speciaRevenue split N/A
Geographical Revenue Split
Domestic vs international exposure
Domestic
0.0%
International
100.0%
Domestic Sales92.5%
Export Sales7.5%
Strategic Relations
Collaborations, joint ventures & subsidiaries
No collaborations data available.
Forensic Metrics
Financial health & earnings-quality indicators
Revenue Quality
N/A
Days Sales Outstanding
Leverage
0.17x
Debt-to-Equity
Earnings Quality
N/A
Cash Conversion Ratio
Efficiency
N/A
Asset Turnover
Earnings Quality
N/A
Accruals Ratio
Profitability
N/A
Gross Margin
Growth
47.1%
Sales Growth
These metrics are derived from available financial disclosures and market data. Use them together with company filings and qualitative analysis before making decisions.